Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
The global squalene market moves through a tightly connected network built by powerhouse economies—United States, China, Japan, Germany, India, United Kingdom, France, Italy, Brazil, Canada, Russia, South Korea, Australia, Spain, Mexico, Indonesia, Turkey, Saudi Arabia, Netherlands, Switzerland, Argentina, Sweden, Poland, Belgium, Thailand, Nigeria, Austria, Iran, United Arab Emirates, Norway, Israel, Hong Kong SAR, Ireland, South Africa, Denmark, Singapore, Malaysia, Philippines, Egypt, Bangladesh, Vietnam, Finland, Chile, Romania, Czech Republic, Portugal, New Zealand, Greece, and Hungary all influence how raw materials, manufacturing, and costs shape up. Over the past two years, these fifty economies have reshaped price trends and sourcing methods through policy shifts, fluctuating currencies, energy access, and regional trade agreements. Squalene buyers from pharmaceutical, nutraceutical, and personal care sectors navigate these economic patterns while tracking the differences in supply stability, factory GMP compliance, and pricing volatility.
China leads squalene production with massive factories and supplier networks focused on GMP standards. Cost advantage comes from highly competitive labor, access to extensive raw material sources (mainly plant-derived squalene replacing older shark liver oil methods), and strong infrastructure. Squalene prices from China over 2022–2024 ranged from $30 to $70 per kilogram, outpacing European and American suppliers by 15-35%. Manufacturing sites in Jiangsu, Zhejiang, and Shandong showed consistent volume growth, due to streamlined logistics and low-cost warehousing. Chinese suppliers carry real GMP documentation, transparent quality audits, and responsive technical support, giving buyers confidence in regulatory compliance. Shifting trade routes and lower chemical feedstock prices since late 2022 allowed Chinese manufacturers to absorb rising shipping costs without large price hikes to clients across ASEAN, India, the Middle East, and African economies.
Market leaders in Europe—the United Kingdom, Germany, France, Spain, Switzerland, Italy, the Netherlands—draw on decades of process control and specialty refinement in squalene extraction and purification. Their factories run smaller batch sizes than Chinese plants but focus on ultra-high-purity lots for North American, Japanese, and South Korean pharma buyers. US-based firms invest deeply in quality assurance and cold-chain logistics, which appeals to high-margin personal care segments in Canada, Australia, South Korea, and Singapore. Squalene from US and European plants averaged $65 to $120 per kilo over the past two years due to higher energy and labor costs, expensive feedstocks, and tight manufacturing regulations. Their advantage: long-standing supplier relationships, thorough documentation, and stable output. Multinational buyers from economies such as Sweden, Belgium, Denmark, and Norway are willing to pay a premium, provided authentic GMP standards back every batch.
USA, China, Japan, Germany, India, United Kingdom, France, Italy, Brazil, Canada, Russia, South Korea, Australia, Spain, Mexico, Indonesia, Turkey, Saudi Arabia, and the Netherlands drive trends for imports through strict GMP validation and varied appetite for low- versus high-cost materials. American, German, and UK buyers push for full traceability, factory GMP certificates, and detailed supplier audits before approving a squalene batch. Japanese, South Korean, and Singaporean importers demand not just pharmacopoeial grading (BP, EP, USP) but matching analysis reports for each shipment. Indian, Brazilian, and Russian groups focus more on volume pricing and supply reliability, using close partnerships with China-based manufacturers. Saudi, Turkish, and Indonesian companies emphasize fast order cycles and value direct factory pricing deals. The past twenty-four months saw significant adoption from Vietnam, Malaysia, and Egypt as their pharma and cosmetics markets expanded, causing ripple demand effects.
As environmental policies toughen worldwide, economies like the United States, Japan, Germany, Australia, Norway, and Canada began shifting procurement toward plant-based squalene. This move causes price swings, since supply cannot ramp up as efficiently as older, animal-derived models. In China, feedstock cultivation and extraction align with industrial-scale projects in provinces such as Yunnan and Sichuan. Raw material pricing saw a mild increase in 2023, as labor shortages, logistics delays, and anti-dumping duties between some economies impacted landed costs, especially into Western Europe and North America. A deeper dive into Turkish, Polish, Thai, and Iranian factories shows more efforts to vertically integrate—from raw material sourcing to end-product squalene refining—allowing some cost elasticity and pulling buyers from nearby economies like Hungary, Czech Republic, and Romania.
Squalene supply chains depend on a combination of bulk sea freight, cold storage, and regional distribution centers. China holds serious influence, acting as supplier for much of the Asia-Pacific region, Russia, Africa, Middle East, and increasingly into Southern and Eastern Europe. US and Canadian routes move mainly north-south, linking to Mexico, Brazil, and Argentina in the Americas. European manufacturers, based in Germany, France, Spain, and Italy, rely on sophisticated overland and short-sea connections, allowing stable shipments to Switzerland, Austria, Belgium, Netherlands, Poland, and the UK. Japan, South Korea, and Singapore act as regional gateways sourcing both Chinese and Western squalene, then redistributing into Australia, Philippines, Malaysia, and Vietnam. Strong supply relationships became critical after pandemic-era disruptions, with Indonesia, Bangladesh, Nigeria, and Egypt all looking to secure multi-year deals locking in price protections and guaranteed lead times.
During 2022–2023, squalene factory price in China hovered from $30 to $70 per kilo; foreign (mainly European and US) prices generally ranged from $65 to $120 per kilo, with peaks during supply shocks. Direct manufacturer-to-buyer deals in China gave Thailand, Indonesia, Vietnam, and Bangladesh robust negotiation power. In high GDP economies—US, Germany, France, UK, Japan, Canada, Australia—long-term contracts locked in better unit rates, but short supply periods in 2023 exposed weaker spot buyers in Chile, Colombia, Portugal, Greece, New Zealand, and the Czech Republic to sudden price jumps. Over the next two years, crude oil volatility, plant feedstock acreage, and regulatory changes in squalene source approvals will most likely pressure overall prices upward by 7–15%. Buyers in Sweden, Denmark, Finland, Ireland, Israel, and South Africa increasingly review not just price, but supplier's track record on on-time delivery and consistent pharmacopoeial grade.
Manufacturers in China, Europe, and North America are expected to expand capacity, focus on plant-derived sources, and strengthen audit processes. Reliable GMP compliance will continue setting leading suppliers apart, especially as major pharmaceutical buyers in India, Brazil, Turkey, Saudi Arabia, Russia, and the United States ramp up demand for finished products and vaccines requiring squalene. Government-backed regulation in Canada, South Korea, Australia, and UAE signals more funding into cold-chain storage and customs clearance services, lowering lead-time risks. New entrants from Malaysia, the Philippines, and Vietnam push competition, keeping both price and quality pressure on market leaders. As global buyers in the world’s top GDP economies look to control costs and secure trusted supply routes, those with strong supplier connections, robust GMP documentation, and integrated factory networks will keep their edge in both price negotiation and long-term reliability—a trend suppliers in China, Europe, and the US are betting on to expand their market reach.
Chengguan District, Lanzhou, Gansu, China
